Literature DB >> 26335975

Trends in Guillain-Barré syndrome mortality in Spain from 1999 to 2013.

Elena Ruiz1, Enrique Ramalle-Gómara1, Carmen Quiñones1, Eva Martínez-Ochoa1.   

Abstract

BACKGROUND: Guillain-Barré syndrome (GBS) is a rare disease that consists of a group of neuropathic conditions. Very few epidemiological studies of GBS have been carried out in Spain. The aim of this study was to determine the trends in GBS mortality in the total population of Spain for the period 1999 to 2013.
METHODS: Data on GBS deaths were drawn from the National Statistics Institute of Spain. Crude and overall age-standardised GBS mortality rates were calculated and joinpoint regression models were used to describe trend changes. Mean age of deceased by GBS each year was also assessed.
RESULTS: The overall age-standardised GBS mortality rate was 0.71 per million in 1999 and 0.40 in 2013. It was higher in men, 1.08 vs. 0.42 in 1999 and 0.48 vs. 0.35 in 2013. There was a statistically significant decrease in mortality during the study period. All the age-standardised mortality rates decreased (overall and by gender) from 1999 to 2013. The mean age at death increased with time, from 73 years in 1999 to 77 years in 2013.
CONCLUSIONS: GBS mortality has improved in Spain during the last 15 years. The age of death has risen and the mortality rate has decreased.

Entities:  

Keywords:  Guillain–Barré syndrome; international classification of diseases; mortality rate; registries; surveillance; trend

Mesh:

Year:  2015        PMID: 26335975     DOI: 10.3109/00207454.2015.1090437

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  4 in total

1.  Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019.

Authors:  Alberto Raggi; Lorenzo Monasta; Ettore Beghi; Valeria Caso; Giulio Castelpietra; Stefania Mondello; Giorgia Giussani; Giancarlo Logroscino; Francesca Giulia Magnani; Marco Piccininni; Elisabetta Pupillo; Stefano Ricci; Luca Ronfani; Paola Santalucia; Davide Sattin; Silvia Schiavolin; Claudia Toppo; Eugenio Traini; Jaimie Steinmetz; Emma Nichols; Rui Ma; Theo Vos; Valery Feigin; Matilde Leonardi
Journal:  J Neurol       Date:  2021-09-08       Impact factor: 6.682

2.  A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments.

Authors:  David G Gonsalvez; Jessica L Fletcher; Sang Won Yoo; Rhiannon J Wood; Simon S Murray; Junhua Xiao
Journal:  J Vis Exp       Date:  2017-11-09       Impact factor: 1.355

3.  Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014).

Authors:  Louise Rose; Douglas McKim; David Leasa; Mika Nonoyama; Anu Tandon; Yu Qing Bai; Reshma Amin; Sherri Katz; Roger Goldstein; Andrea Gershon
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

4.  Severe Acute Motor Axonal Neuropathy associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report.

Authors:  Oana Mosora; Laura Barcutean; Rodica Balasa; Raluca Fodor; Smaranda Maier; Zoltan Bajko; Adina Stoian; Anca Motataianu
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.